Medicines for Jihnem
Original notice title
Léčiva pro Jihnem (152026)
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
40 / 100
Risk factors
Essential eligibility and technical requirements are not provided in the notice; full procurement documents must be rev...
All submission documents must be in Czech; non-Czech bidders face translation costs and potential errors.
Submission deadline in 5 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 89.4M estimated value
- Supplies contract
- 2 lots
- Regular supply of medicinal preparations classified under ATC groups (specific details in procurement documents).
- Lot 1: Bevacizumab (ATC L01FG01).
Show full summary
Open tender for supply of medicinal products (ATC groups) to Jihočeské nemocnice, a.s. in Czech Republic. Two lots: Lot 1 (Bevacizumab) and Lot 2 (unspecified), both with 48-month contracts. Award based solely on lowest price. No selection criteria or required documents specified in notice. Procurement documents available online but not analyzed.
Risks
Essential eligibility and technical requirements are not provided in the notice; full procurement documents must be rev...
All submission documents must be in Czech; non-Czech bidders face translation costs and potential errors.
Submission deadline in 5 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Contract duration: 48 months from planned start (2026-09-01).
Administrative
- Electronic submission required via profile (Open portal).
- Tenders must be submitted in Czech language (CES).
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Buyer
Name
Jihočeské nemocnice, a.s.
Location
České Budějovice, CZE
Buyer profile
Identifier
26093804
Lots (2)
LOT-0001
Léčiva pro Jihnem (152026) - Část 1 L01FG01 BEVACIZUMAB
Supply of Bevacizumab medicinal products (ATC group L01FG01) over 48 months.
CZK 61.5M
Estimated value
Location
Category
Deadline
Award details
Value note
Show original TED data
Original TED description
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků rozdělených do jednotlivých anatomicko-terapeuticko-chemických skupin (tzv. ATC skupin).
LOT-0002
LOT-0002
Supply of unspecified medicinal products (ATC group 33697000) over 48 months.
CZK 27.9M
Estimated value
Location
Category
Deadline
Value note
Procurement Details
- Publication date
- 28 May 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 367245-2026
- Source notice ID
- e6200e9d-3da6-4f9a-bfb8-7024b5f80405
Documents (1)
Similar tenders
Czechia – Medical preparations excluding dental consumables – Léčiva pro Jihnem (152026)
Czechia – Medical preparations excluding dental consumables – Léčiva pro Jihnem (162026) - B01AB05 ENOXAPARIN - Clexane; pro veřejnou část nemocniční lékárny
Finland – Medical equipments – DPS Ortopediset tarvikkeet, implantit ja biomateriaalit
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
40 / 100
Risk factors
Essential eligibility and technical requirements are not provided in the notice; full procurement documents must be rev...
All submission documents must be in Czech; non-Czech bidders face translation costs and potential errors.
Submission deadline in 5 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications